Showing results (1081-1090 of 1,702) with videos related to

Sort By:
Pageof 171
Cancer Chemotherapy and Pharmacology|October 29, 2015
Phase II study of lapatinib and capecitabine in second-line treatment for metastatic pancreatic cancerZheng Wu, Andrew Gabrielson, Jimmy J Hwang, et al.
Chemistry (Weinheim an Der Bergstrasse, Germany)|July 12, 2017
Expanded Indacene-Tetrathiafulvalene Scaffolds: Structural Implications for Redox Properties and Association BehaviorJohannes Fabritius Petersen, Conerd K Frederickson, Jonathan L Marshall, et al.
Cancer Immunology, Immunotherapy : CII|December 29, 2000
The use of a rapid ELISPOT assay to analyze peptide-specific immune responses in carcinoma patients to peptide vs. recombinant poxvirus vaccinesP Arlen, K Y Tsang, J L Marshall, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|March 7, 2020
Hemostatic prophylaxis and colonoscopy outcomes for patients with bleeding disorders: A retrospective cohort study and review of the literatureSarah M Azer, Amy L Eckerman, Vilmarie Rodriguez, et al.
Molecular Carcinogenesis|December 25, 2018
Camphor white oil induces tumor regression through cytotoxic T cell-dependent mechanismsYalda Moayedi, Sophie A Greenberg, Blair A Jenkins, et al.
The American Journal of Drug and Alcohol Abuse|June 25, 2024
Missouri's Overdose Field Report: descriptive analysis, survival trends, and naloxone dosing patterns from a community-based survey tool, 2018-2022Zach Budesa, Kyle Vance, Ryan Smith, et al.
Journal of Substance Use and Addiction Treatment|June 11, 2026
Healthcare provider approaches to managing the health harms of xylazine: A qualitative studyPatrick J A Kelly, Amelia Bailey, Josiah D Rich, et al.
Journal of Urban Health : Bulletin of the New York Academy of Medicine|June 7, 2019
Willingness to Use Safe Consumption Spaces among Opioid Users at High Risk of Fentanyl Overdose in Baltimore, Providence, and BostonJu Nyeong Park, Susan G Sherman, Saba Rouhani, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 3, 1999
A Phase I and pharmacokinetic study of TNP-470 administered weekly to patients with advanced cancerP Bhargava, J L Marshall, N Rizvi, et al.
Pageof 171